Zobrazeno 1 - 10
of 20
pro vyhledávání: '"James S Welsh"'
Autor:
BhanuPrasad, Venkatesulu, Prashanth, Giridhar, Lincoln, Pujari, Brian, Chou, Jae Han, Lee, Alec M, Block, Rituraj, Upadhyay, James S, Welsh, Matthew M, Harkenrider, Sunil, Krishnan, Vivek, Verma, Cheng, En Hsieh, Satyajit, Pradhan, William, Small, Abhishek A, Solanki
Publikováno v:
Radiotherapy and Oncology. 177:81-94
Radiation-related lymphopenia has been associated with suboptimal tumor control rates leading to inferior survival outcomes. To date, no standardized dose constraints are available to limit radiation dose to resident and circulating lymphocyte popula
Autor:
Babak PeyroShabany, Mansoureh Dehghani, Seyed Alireza Javadinia, Danial Fazilat-Panah, Pejman Porouhan, Farbod Hatami, James S Welsh, Maryam Nabavifard, Mona Ariamanesh, Mohammad Fereidouni
Publikováno v:
Cancer Investigation
article-version (VoR) Version of Record
article-version (VoR) Version of Record
ObjectivePatients with malignancy suffer from a compromised immune system due to either the effects of malignancies or treatments. Cancer patients are at higher risk of different infections particularly SARS-CoV2 and usually produce weaker response t
Autor:
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, Fateme Nikbakht, Farzaneh Dashti, Maryam Joudi, Hadi Harati, James S. Welsh, Seyed Amir Farahmand, Fahimeh Attarian
Publikováno v:
Frontiers in endocrinology. 13
BackgroundData on the efficacy and safety of COVID-19 vaccines in patients with malignancy are immature. In this paper, we assessed the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the
Autor:
Mansoureh Dehghani, Pejman Porouhan, Mona Ariamanesh, Farbod Hatami, Somayeh Ashkar Tizabi, Gary H. Lyman, Babak PeyroShabany, James S Welsh, Seyed Alireza Javadinia, Maryam Nabavifard, Danial Fazilat-Panah, Ahmad Ghasemi
Publikováno v:
Cancer investigation. 40(2)
Patients with cancer are at significantly greater risk of COVID-19 and its complications than the general population. Since IgG antibodies remain detectable well after infection with the SARS-CoV-2 virus, seroprevalence can be used to estimate the pr
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 22(10)
Publikováno v:
International Journal of Radiation Biology
This letter addresses our concerns regarding the paper entitled “The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtua...
Publikováno v:
Critical reviews in oncology/hematology. 160
The results of clinical trials performed from the 1930s until the end of the 20th century in which total-body ultra-low level ionizing radiation (TB-LLR) was used demonstrate that this form of treatment can be equal or superior to other systemic anti
Autor:
James S Welsh, Ali S Megooni, Mansoor M. Ahmed, Sha Chang, Xiaodong Wu, Charles B. Simone, Robert J. Griffin, Xin Zhang, Hualin Zhang, N.A. Mayr, Eric D. Donnelly
Publikováno v:
Radiation research. 194(6)
The limits of radiation tolerance, which often deter the use of large doses, have been a major challenge to the treatment of bulky primary and metastatic cancers. A novel technique using spatial modulation of megavoltage therapy beams, commonly refer
Autor:
Yi Rong, James S. Welsh
Publikováno v:
American Journal of Clinical Oncology. 33:646-649
Besides photons and electrons, high-energy particles like protons, neutrons, ⁴He ions or heavier ions (C, Ne, etc) have been finding increasing applications in the treatment of radioresistant tumors and tumors located near critical structures. The
Autor:
Steven P. Howard, James S. Welsh, Paul M. Harari, Wolfgang A. Tomé, David Diamond, Jeffery P. Limmer
Publikováno v:
Technology in Cancer Research & Treatment. 4:203-210
Intensity-modulated radiation therapy (IMRT) represents a significant technological advancement in the ability to deliver highly conformal radiation therapy. Thanks to increased availability, general clinical implementation has become progressively m